Human Protein Turnover Project - HuPTuP

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 35 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•- Age 18 to 85 years;
•- Compos mentis;
•- Surgical intervention for oesophagus carcinoma, colon carcinoma, aortic valve insufficiency, lung carcinoma, renal cell carcinoma, epilepsy and hip fracture;
•- Written informed consent.

•- Co-morbidities and neuromuscular disorders of the lower limbs severely interacting with mobility with limited or no opportunity for improvement (e.g. cerebral palsy);
•- Peripheral arterial disease Fontaine III or IV;
•- Chronic obstructive pulmonary disease (COPD) GOLD III or IV;
•- Use of systemic steroids in the past four weeks, other than indicated for the specific type of surgery;
•- Use anti-inflammatory biologicals (e.g. TNF-alfa blockers) in the past four weeks;
•- Phenylketonuria (PKU);
•- Surgical intervention in the past four weeks;
•- Insulin dependent diabetes mellitus;
•- Total parenteral nutrition at day of surgery;
•- Pregnancy;
•- Neoadjuvant chemo- or radiotherapy in the past four weeks.

发起方

Medisch Universitair Ziekenhuis Maastricht